Natixis Teva Pharmaceutical Industries LTD Transaction History

Natixis

  • $17.4 Billion
  • Q2 2024

A detailed history of Natixis transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Natixis holds 2,734 shares of TEVA stock, worth $46,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,734
Holding current value
$46,778
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$12.78 - $17.4 $34,940 - $47,571
2,734 New
2,734 $44,000
Q4 2022

Feb 24, 2023
BUY
$7.95 - $9.48 $52,986 - $63,184
6,665 New
6,665 $60,000
Q2 2022

Aug 12, 2022
SELL
$7.38 - $10.4 $69,460 - $97,884
-9,412 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$7.33 - $9.39 $676,778 - $866,978
-92,330 Reduced 90.75%
9,412 $88,000
Q4 2021

Feb 14, 2022
SELL
$7.9 - $10.19 $119,266 - $153,838
-15,097 Reduced 12.92%
101,742 $815,000
Q3 2021

Nov 12, 2021
BUY
$8.38 - $10.18 $979,110 - $1.19 Million
116,839 New
116,839 $1.14 Million
Q2 2021

Aug 13, 2021
SELL
$9.9 - $11.56 $1.1 Million - $1.29 Million
-111,393 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$10.34 - $12.81 $93,049 - $115,277
8,999 Added 8.79%
111,393 $1.29 Million
Q4 2020

Feb 12, 2021
SELL
$8.61 - $11.04 $111,818 - $143,376
-12,987 Reduced 11.26%
102,394 $987,000
Q3 2020

Nov 12, 2020
SELL
$8.57 - $12.69 $2.54 Million - $3.76 Million
-296,109 Reduced 71.96%
115,381 $1.04 Million
Q2 2020

Aug 13, 2020
BUY
$8.12 - $13.12 $1.59 Million - $2.57 Million
195,647 Added 90.64%
411,490 $5.07 Million
Q1 2020

May 14, 2020
SELL
$6.69 - $13.45 $330,338 - $664,134
-49,378 Reduced 18.62%
215,843 $1.94 Million
Q4 2019

Feb 14, 2020
BUY
$6.53 - $10.72 $73,390 - $120,482
11,239 Added 4.43%
265,221 $2.58 Million
Q3 2019

Nov 13, 2019
BUY
$6.16 - $9.6 $115,241 - $179,596
18,708 Added 7.95%
253,982 $1.75 Million
Q2 2019

Aug 13, 2019
BUY
$8.12 - $15.72 $1.36 Million - $2.63 Million
167,083 Added 245.02%
235,274 $2.17 Million
Q1 2019

May 15, 2019
SELL
$15.58 - $20.01 $8.1 Million - $10.4 Million
-519,605 Reduced 88.4%
68,191 $1.06 Million
Q4 2018

Feb 14, 2019
BUY
$14.59 - $23.84 $731,352 - $1.2 Million
50,127 Added 9.32%
587,796 $9.06 Million
Q3 2018

Nov 14, 2018
BUY
$21.06 - $25.65 $9.57 Million - $11.7 Million
454,546 Added 546.84%
537,669 $11.6 Million
Q2 2018

Aug 14, 2018
SELL
$16.77 - $24.71 $2.83 Million - $4.18 Million
-168,992 Reduced 67.03%
83,123 $2.02 Million
Q1 2018

May 15, 2018
BUY
$16.68 - $22.07 $3.43 Million - $4.54 Million
205,655 Added 442.65%
252,115 $4.31 Million
Q4 2017

Feb 14, 2018
SELL
$11.23 - $19.1 $677,023 - $1.15 Million
-60,287 Reduced 56.48%
46,460 $865,000
Q3 2017

Nov 14, 2017
BUY
$15.41 - $32.17 $15,132 - $31,590
982 Added 0.93%
106,747 $1.87 Million
Q2 2017

Aug 14, 2017
BUY
N/A
105,765
105,765 $3.51 Million

Others Institutions Holding TEVA

# of Institutions
624
Shares Held
565M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email